Tradestie Institutional Equity Comparison Engine

MRVI vs ARVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ARVN Overall Edge

ARVN Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arvinas, Inc (ARVN) driven by superior Valuation, Growth & Margin while MRVI counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, MRVI trades at N/M Forward P/E with -24.2% operating margin (+10.1% YoY revenue) versus ARVN at 17.9x Forward P/E and -10.1% operating margin (-98.8% YoY). In options structure, MRVI sits in BREAKOUT (17th %ile IV; Dealer Gamma Walls on Pro) against ARVN sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ARVN
MRVI N/M vs ARVN 17.9x Fwd P/E
Growth & Margin Winner ARVN
Op Margin -24.2% vs -10.1% ยท YoY +10.1% vs -98.8%
Momentum & Technical Winner MRVI
1Y +129.2% vs -33.4% ยท 52W Pos 70% vs 5%
Options & Structure Winner MRVI
BREAKOUT (17th %ile IV) vs BREAKDOWN (25th %ile IV)
MRVI NASDAQ
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Pharmaceutical Preparations
$7.45
-1.19% 1D
Market Cap $2.0B
1M Return +9.72%
1Y Return +129.23%
Forward P/E N/M
Unified AI Score
49.0 / 100 HOLD
Tech 37.0 Fund 48.0 Flow 67.0 Mom 64.0
ARVN NASDAQ
Arvinas, Inc
Pharmaceutical Preparations
$6.74
-1.17% 1D
Market Cap $449.9M
1M Return -3.3%
1Y Return -33.4%
Forward P/E 17.9x
Unified AI Score
52.9 / 100 HOLD
Tech 54.0 Fund 59.0 Flow 71.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MRVI +129.23% ARVN -33.4% Spread: +162.63 pp (MRVI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MRVI Revenue ARVN Revenue MRVI Op. Margin ARVN Op. Margin Margin Edge
FY2018 N/A $10M N/A -306.3% ARVN
FY2019 $140M $20M 16.8% -281.4% MRVI
FY2020 $280M $20M 42.2% -554.1% MRVI
FY2021 $800M $50M 69.4% -403.4% MRVI
FY2022 $880M $130M 65.0% -200.3% MRVI
FY2023 $290M $80M -11.0% -511.5% MRVI
FY2024 $260M $260M -90.9% -95.0% MRVI
FY2025 $190M $260M -115.9% -45.1% ARVN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MRVI (3) vs ARVN (7)
Institutional Metric MRVI ARVN Criterion Row Winner
Market Capitalization Scale $2.0B $449.9M Larger Scale MRVI
Trailing P/E Ratio Valuation N/M 17.9x Lower Multiple ARVN
Forward P/E Ratio Valuation N/M 17.9x Lower Multiple ARVN
Revenue Growth (YoY) Growth +10.1% -98.8% Higher Growth MRVI
Operating Margin (TTM) Profitability -24.2% -10.1% Higher Margin ARVN
Net Profit Margin Profitability -30.8% -3.5% Higher Margin ARVN
Return on Equity (ROE) Capital Efficiency -29.8% -1.8% Higher ROE ARVN
52-Week Range Position Momentum 70% ($3โ€“$9) 5% ($6โ€“$15) Stronger Trend MRVI
Beta / 30D Volatility Risk Regime 1.61ฮฒ ยท 83% Vol 1.40ฮฒ ยท 66% Vol Lower Realized Risk ARVN
Unified Institutional Score Composite Signal 49.0 / 100 (HOLD) 52.9 / 100 (HOLD) Higher Composite ARVN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MRVI vs ARVN Buy Guide
MRVI BREAKOUT
98d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live MRVI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ARVN BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ARVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MRVI nor ARVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.